| Patents for C07K 19 - Hybrid peptides (29,428) |
|---|
| 08/04/1999 | EP0932681A2 Compounds and methods for immunotherapy and diagnosis of tuberculosis |
| 08/04/1999 | EP0932680A2 Compositions and methods for the prevention and diagnosis of human granulocytic ehrlichiosis |
| 08/04/1999 | EP0932417A1 Non-antigenic toxin-conjugate and fusion protein of internalizing receptor system |
| 08/04/1999 | EP0567585B1 Hepatic growth factor receptor is the met proto-oncogene |
| 08/04/1999 | CN1225130A Human B-cell antigens, related reagents |
| 08/04/1999 | CN1225129A Chimeric heteromultimer adhesins |
| 08/04/1999 | CN1044479C Process for preparation of anti-thrombin polypeptides |
| 08/03/1999 | US5932477 This novel enzyme is particularly useful for screening candidate compounds for their ability to serve as potential anti-depressant, antiasthmatic or anti-inflammatory agents. |
| 08/03/1999 | US5932476 Cloning of chicken anemia virus DNA |
| 08/03/1999 | US5932471 DNA encoding chimeric toxin |
| 08/03/1999 | US5932447 Use of purified oligonucleotides encoding the ribosome-inactivating protein for the expression of a ribosome-inactivating protein (rip) and in the construction of fusion proteins is also considered part of the present |
| 08/03/1999 | US5932440 Mammalian ribonuclease inhibitors and use thereof |
| 08/03/1999 | US5932218 Multideterminant peptides eliciting helper T-lymphocyte, cytotoxic T-lymphocyte, and neutralizing antibody responses against HIV-1 |
| 07/29/1999 | WO1999037818A1 Novel molecules of the tnf receptor superfamily and uses therefor |
| 07/29/1999 | WO1999037791A1 Multipurpose antibody derivatives |
| 07/29/1999 | WO1999037773A1 Acpl dna and polypeptides |
| 07/29/1999 | WO1999037772A1 Il-18 receptors |
| 07/29/1999 | WO1999037769A1 Orphan receptors |
| 07/29/1999 | WO1995030750A8 Lag-3 protein soluble polypeptide fractions, method of production, therapeutic composition and anti-idiotype antibody |
| 07/29/1999 | CA2319208A1 Orphan receptors |
| 07/29/1999 | CA2318743A1 Novel molecules of the tnf receptor superfamily and uses therefor |
| 07/29/1999 | CA2317727A1 Multipurpose antibody derivatives |
| 07/28/1999 | EP0931836A1 Vasopermeability enhancing peptide of human interleukin-2 and immunoconjugates thereof |
| 07/28/1999 | EP0931162A1 Production of a multimeric protein by cell fusion method |
| 07/28/1999 | EP0931148A1 Fibroblast growth factor homologs |
| 07/28/1999 | EP0678122B1 Recombinant anti-vla4 antibody molecules |
| 07/27/1999 | US5929222 Expression of a foamy virus envelope protein |
| 07/27/1999 | US5929212 CD3 specific recombinant antibody |
| 07/27/1999 | US5928917 A conjugate of nonprotein selected from tag, antibiotic, fungicide, insecticide and texturing agent joined to a nonfusion polypeptide having amino acid sequence coprising a substrate binding region of cellulase binds with 1,4-glucan |
| 07/27/1999 | US5928901 Molecules containing at least one peptide sequence carrying one or several epitopes characteristic of a protein produced by P. falciparum in hepatocytes and compositions containing them |
| 07/22/1999 | WO1999036561A1 Use of a proline-rich sequence to improve the fusogenic character of retroviral envelopes |
| 07/22/1999 | WO1999036553A2 Regulation of biological events using multimeric chimeric proteins |
| 07/22/1999 | WO1999036552A1 Method for producing purified and optionally marked tsh receptor preparations, radioiodized tsh receptor preparations and the use of preparations of this type in diagnostics and therapy |
| 07/22/1999 | WO1999036537A2 Fatty acid transport proteins |
| 07/22/1999 | WO1999036437A1 Antibody/receptor targeting moiety for enhanced delivery of armed ligand |
| 07/22/1999 | WO1999036093A1 Methods of using human receptor protein 4-1bb |
| 07/22/1999 | CA2318525A1 Methods of using human receptor protein 4-1bb |
| 07/22/1999 | CA2318402A1 Regulation of biological events using multimeric chimeric proteins |
| 07/22/1999 | CA2318363A1 Fatty acid transport proteins |
| 07/22/1999 | CA2318284A1 Antibody/receptor targeting moiety for enhanced delivery of armed ligand |
| 07/22/1999 | CA2317026A1 Use of a proline-rich sequence to improve the fusogenic character of retroviral envelopes |
| 07/21/1999 | EP0930366A2 Binding domains in delta proteins |
| 07/21/1999 | EP0930365A2 Binding domains in serrate protein |
| 07/21/1999 | EP0929691A2 Methods and compositions for identifying receptor effectors |
| 07/21/1999 | EP0929670A1 P-selectin ligand proteins |
| 07/21/1999 | CN1223690A Antiangiogenic peptides derived from plasminogen, its coded polynucleotide and method of inhibiting vascularization |
| 07/21/1999 | CN1223377A Cellulose binding domain |
| 07/20/1999 | US5925549 Soluble 7-transmembrane domain G-protein-coupled receptor compositions and methods |
| 07/20/1999 | CA2137638C Anti gangliosides monoclonal antibodies and their use in the specific active immunotherapy of malignant tumors |
| 07/20/1999 | CA2082394C Pseudomonas exotoxins of low animal toxicity and high cytocidal activity |
| 07/20/1999 | CA2053921C Synthetic peptides for an hiv-1 vaccine |
| 07/20/1999 | CA1340656C Membrane anchor/active compound conjugate, its preparation and its use |
| 07/15/1999 | WO1999035276A1 Mammalian matrix-type metalloprotease |
| 07/15/1999 | WO1999035270A1 Streptococcal heat shock proteins of the hsp60 family |
| 07/15/1999 | WO1999035260A1 Non-identical genes and their application in improved molec ular adjuvants |
| 07/15/1999 | WO1999023867A3 Bmog, a protein member of the myelin-oligodendrocyte glycoprotein family and its use |
| 07/15/1999 | WO1999013095A9 Use of multivalent chimeric peptide-loaded, mhc/ig molecules to detect, activate or suppress antigen-specific t cell-dependent immune responses |
| 07/15/1999 | DE19801154A1 Preparation of pure recombinant thyroid stimulating hormone receptor useful for detection of autoantibodies in human serum |
| 07/15/1999 | CA2317696A1 Mammalian matrix-type metalloprotease |
| 07/15/1999 | CA2317020A1 Non-identical genes and their application in improved molecular adjuvan ts |
| 07/15/1999 | CA2315880A1 Streptococcal heat shock proteins of the hsp60 family |
| 07/14/1999 | EP0531434B1 Improved pseudomonas exotoxins of low animal toxicity and high cytocidal activity |
| 07/13/1999 | US5922854 Purifying Human Hemogloblin from transgenic pig red cells and plasmids containing pig globin nucleic acids |
| 07/13/1999 | US5922845 Therapeutic multispecific compounds comprised of anti-Fcα receptor antibodies |
| 07/13/1999 | US5922584 Method for promoting enzyme diversity |
| 07/13/1999 | CA2121257C Stabilised antibodies |
| 07/13/1999 | CA1340649C Purified follicle stimulating hormone |
| 07/13/1999 | CA1340641C Recombinant lymphotoxin |
| 07/08/1999 | WO1999034005A1 Maize h3c4 promoter associated with first rice actin intron, chimeric gene containing it and transformed plant |
| 07/08/1999 | WO1999034004A2 Metastatic breast and colon cancer regulated genes |
| 07/08/1999 | WO1999033965A1 Bifunctional molecules |
| 07/08/1999 | WO1999033963A1 Metastatic cancer regulated gene |
| 07/08/1999 | WO1999033868A2 Human papillomavirus vaccine |
| 07/08/1999 | WO1999033488A2 Adjuvanted vaccine formulation |
| 07/08/1999 | WO1999010510A3 Fusion proteins comprising a dimerization, trimerization or tetramerization domain and an additional heterologous transcription activation, transcription repression, dna binding or ligand binding domain |
| 07/08/1999 | CA2315944A1 Bifunctional molecules |
| 07/08/1999 | CA2315276A1 Human papillomavirus vaccine |
| 07/07/1999 | EP0927758A2 Recombinant antibodies specific for TNF-Alpha |
| 07/07/1999 | EP0927254A1 Antagonists of interleukin-15 |
| 07/07/1999 | CN1222193A Extracellular matrix signalling molecules |
| 07/07/1999 | CN1221754A Thrombocytopoiesis pill, macrophage excited factor fusion protein and its application |
| 07/07/1999 | CN1221753A Front surface antigenic protein guide medicine for hepatitis B virus |
| 07/06/1999 | US5919905 Cytokine designated LERK-6 |
| 07/06/1999 | US5919903 Low affinity human IL-12 beta2 receptor |
| 07/06/1999 | US5919637 Method for identifying reduced binding between GMP-140 and GMP-140 ligand |
| 07/06/1999 | US5919615 Polypeptides and antibodies characteristic of papillomavirus, and diagnostic procedures and vaccines making use of them |
| 07/06/1999 | US5919456 IL-13 receptor specific chimeric proteins |
| 07/06/1999 | US5919454 Nucleotide and peptide sequences of a hepatitis C virus isolate, diagnostic and therapeutic applications |
| 07/06/1999 | CA2000604C Process for the activation of genetechnologically produced, biologically-active proteins expressed in prokaryotes |
| 07/01/1999 | WO1999032634A2 Compositions derived from mycobacterium vaccae and methods for their use |
| 07/01/1999 | WO1999032620A1 Insulin-like growth factor binding protein fragments and the utilization thereof |
| 07/01/1999 | WO1999032520A1 Method for quantitating denatured ldls |
| 07/01/1999 | WO1999032141A1 Ifnar2/ifn complex |
| 07/01/1999 | WO1999019470A3 Gfp-annexin fusion proteins |
| 07/01/1999 | DE19757250A1 Insulin-like growth factor binding protein und seine Verwendung Insulin-like growth factor binding protein and its use |
| 07/01/1999 | CA2315974A1 Insulin-like growth factor binding protein fragments and the utilization thereof |
| 07/01/1999 | CA2315539A1 Compositions derived from mycobacterium vaccae and methods for their use |
| 07/01/1999 | CA2315280A1 Method for quantifying denatured ldl |
| 06/30/1999 | CN1221452A Hybrid interferon compositions and method of use |
| 06/29/1999 | US5917017 Diphtheria toxin vaccines bearing a mutated R domain |